ID DOK5_HUMAN Reviewed; 306 AA. AC Q9P104; Q5T7Y0; Q5TE53; Q8TEW7; Q96H13; Q9BZ24; Q9NQF4; Q9Y411; DT 06-DEC-2002, integrated into UniProtKB/Swiss-Prot. DT 06-DEC-2002, sequence version 2. DT 24-JAN-2024, entry version 180. DE RecName: Full=Docking protein 5; DE AltName: Full=Downstream of tyrosine kinase 5; DE AltName: Full=Insulin receptor substrate 6; DE Short=IRS-6; DE Short=IRS6; GN Name=DOK5; Synonyms=C20orf180; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RA Luo W.Q., Chen J.H., Huang X.W., Zhou Y., Zhou H.J., Hu S.N., Yuan J.G.; RL Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY. RX PubMed=12595900; DOI=10.1038/sj.gene.6363891; RA Favre C., Gerard A., Clauzier E., Pontarotti P., Olive D., Nunes J.A.; RT "DOK4 and DOK5: new Dok-related genes expressed in human T cells."; RL Genes Immun. 4:40-45(2003). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND RP PHOSPHORYLATION AT TYROSINE RESIDUES. RC TISSUE=Skeletal muscle; RX PubMed=12730241; DOI=10.1074/jbc.m212430200; RA Cai D., Dhe-Paganon S., Melendez P.A., Lee J., Shoelson S.E.; RT "Two new substrates in insulin signaling, IRS5/DOK4 and IRS6/DOK5."; RL J. Biol. Chem. 278:25323-25330(2003). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=11780052; DOI=10.1038/414865a; RA Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R., RA Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L., RA Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P., RA Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D., RA Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G., RA Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E., RA Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D., RA Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P., RA Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E., RA Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J., RA Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D., RA Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S., RA Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D., RA Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A., RA Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T., RA Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I., RA Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M., RA Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D., RA Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M., RA Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A., RA Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L., RA Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L., RA Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.; RT "The DNA sequence and comparative analysis of human chromosome 20."; RL Nature 414:865-871(2001). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 42-306 (ISOFORM 1). RC TISSUE=Kidney; RX PubMed=17974005; DOI=10.1186/1471-2164-8-399; RA Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., RA Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., RA Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., RA Wiemann S., Schupp I.; RT "The full-ORF clone resource of the German cDNA consortium."; RL BMC Genomics 8:399-399(2007). RN [7] RP CRYSTALLIZATION. RX PubMed=12454490; DOI=10.1107/s090744490201644x; RA Shi N., Zhou W., Tang K., Gao Y., Jin J., Gao F., Peng X., Bartlam M., RA Qiang B., Yuan J., Rao Z.; RT "Expression, crystallization and preliminary X-ray studies of the RT recombinant PTB domain of human dok-5 protein."; RL Acta Crystallogr. D 58:2170-2172(2002). CC -!- FUNCTION: DOK proteins are enzymatically inert adaptor or scaffolding CC proteins. They provide a docking platform for the assembly of CC multimolecular signaling complexes. DOK5 functions in RET-mediated CC neurite outgrowth and plays a positive role in activation of the MAP CC kinase pathway. Putative link with downstream effectors of RET in CC neuronal differentiation. CC -!- SUBUNIT: Interacts with phosphorylated RET. In contrast to other DOK CC proteins, it does not interact with RASGAP (By similarity). CC {ECO:0000250}. CC -!- INTERACTION: CC Q9P104-2; Q99471: PFDN5; NbExp=3; IntAct=EBI-10692909, EBI-357275; CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q9P104-1; Sequence=Displayed; CC Name=2; CC IsoId=Q9P104-2; Sequence=VSP_003854; CC -!- TISSUE SPECIFICITY: Highest expression in skeletal muscle, lower in CC brain, heart and kidney. Also detected in activated peripheral blood T- CC lymphocytes. {ECO:0000269|PubMed:12595900, CC ECO:0000269|PubMed:12730241}. CC -!- DOMAIN: PTB domain mediates receptor interaction. {ECO:0000250}. CC -!- PTM: Phosphorylated on tyrosine residues in response to insulin, IGF1 CC and GDNF. {ECO:0000269|PubMed:12730241}. CC -!- SIMILARITY: Belongs to the DOK family. Type B subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF132732; AAF66443.1; -; mRNA. DR EMBL; AF466368; AAL74194.1; -; mRNA. DR EMBL; AL118501; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL162292; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC008992; AAH08992.1; -; mRNA. DR EMBL; AL050069; CAB43255.3; -; mRNA. DR CCDS; CCDS13446.1; -. [Q9P104-1] DR CCDS; CCDS13447.1; -. [Q9P104-2] DR PIR; T08731; T08731. DR RefSeq; NP_060901.2; NM_018431.4. [Q9P104-1] DR RefSeq; NP_808874.1; NM_177959.2. [Q9P104-2] DR RefSeq; XP_011527206.1; XM_011528904.1. [Q9P104-2] DR PDB; 1J0W; X-ray; 2.50 A; A/B=133-232. DR PDBsum; 1J0W; -. DR AlphaFoldDB; Q9P104; -. DR SMR; Q9P104; -. DR BioGRID; 120926; 16. DR IntAct; Q9P104; 15. DR MINT; Q9P104; -. DR STRING; 9606.ENSP00000262593; -. DR iPTMnet; Q9P104; -. DR PhosphoSitePlus; Q9P104; -. DR BioMuta; DOK5; -. DR DMDM; 26393190; -. DR MassIVE; Q9P104; -. DR PaxDb; 9606-ENSP00000262593; -. DR PeptideAtlas; Q9P104; -. DR ProteomicsDB; 83627; -. [Q9P104-1] DR ProteomicsDB; 83628; -. [Q9P104-2] DR Antibodypedia; 28805; 437 antibodies from 34 providers. DR DNASU; 55816; -. DR Ensembl; ENST00000262593.10; ENSP00000262593.5; ENSG00000101134.12. [Q9P104-1] DR Ensembl; ENST00000395939.5; ENSP00000379270.1; ENSG00000101134.12. [Q9P104-2] DR GeneID; 55816; -. DR KEGG; hsa:55816; -. DR MANE-Select; ENST00000262593.10; ENSP00000262593.5; NM_018431.5; NP_060901.2. DR UCSC; uc002xwy.4; human. [Q9P104-1] DR AGR; HGNC:16173; -. DR CTD; 55816; -. DR DisGeNET; 55816; -. DR GeneCards; DOK5; -. DR HGNC; HGNC:16173; DOK5. DR HPA; ENSG00000101134; Tissue enhanced (skeletal muscle, tongue). DR MIM; 608334; gene. DR neXtProt; NX_Q9P104; -. DR OpenTargets; ENSG00000101134; -. DR PharmGKB; PA25724; -. DR VEuPathDB; HostDB:ENSG00000101134; -. DR eggNOG; KOG4047; Eukaryota. DR GeneTree; ENSGT00940000160725; -. DR HOGENOM; CLU_057256_1_0_1; -. DR InParanoid; Q9P104; -. DR OMA; MECIGTR; -. DR OrthoDB; 2996885at2759; -. DR PhylomeDB; Q9P104; -. DR TreeFam; TF324994; -. DR PathwayCommons; Q9P104; -. DR Reactome; R-HSA-8853659; RET signaling. DR SignaLink; Q9P104; -. DR SIGNOR; Q9P104; -. DR BioGRID-ORCS; 55816; 12 hits in 1135 CRISPR screens. DR ChiTaRS; DOK5; human. DR EvolutionaryTrace; Q9P104; -. DR GeneWiki; DOK5; -. DR GenomeRNAi; 55816; -. DR Pharos; Q9P104; Tbio. DR PRO; PR:Q9P104; -. DR Proteomes; UP000005640; Chromosome 20. DR RNAct; Q9P104; Protein. DR Bgee; ENSG00000101134; Expressed in ventricular zone and 174 other cell types or tissues. DR GO; GO:0005737; C:cytoplasm; IBA:GO_Central. DR GO; GO:0005829; C:cytosol; TAS:Reactome. DR GO; GO:0030182; P:neuron differentiation; IEA:Ensembl. DR GO; GO:0043410; P:positive regulation of MAPK cascade; IBA:GO_Central. DR GO; GO:0007265; P:Ras protein signal transduction; IBA:GO_Central. DR GO; GO:0051386; P:regulation of neurotrophin TRK receptor signaling pathway; IMP:MGI. DR GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IBA:GO_Central. DR CDD; cd14678; PH_DOK4_DOK5_DOK6; 1. DR CDD; cd13164; PTB_DOK4_DOK5_DOK6; 1. DR Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 2. DR InterPro; IPR037816; DOK4/5/6_PH. DR InterPro; IPR002404; IRS_PTB. DR InterPro; IPR011993; PH-like_dom_sf. DR InterPro; IPR001849; PH_domain. DR PANTHER; PTHR21258:SF45; DOCKING PROTEIN 5; 1. DR PANTHER; PTHR21258; DOCKING PROTEIN RELATED; 1. DR Pfam; PF02174; IRS; 1. DR SMART; SM01244; IRS; 1. DR SMART; SM00233; PH; 1. DR SMART; SM00310; PTBI; 1. DR SUPFAM; SSF50729; PH domain-like; 2. DR PROSITE; PS51064; IRS_PTB; 1. DR Genevisible; Q9P104; HS. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Phosphoprotein; Reference proteome. FT CHAIN 1..306 FT /note="Docking protein 5" FT /id="PRO_0000187277" FT DOMAIN 8..112 FT /note="PH" FT DOMAIN 132..237 FT /note="IRS-type PTB" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00389" FT MOTIF 263..273 FT /note="DKFBH motif" FT VAR_SEQ 1..108 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_003854" FT CONFLICT 225..234 FT /note="SAALAIAEQH -> LLQMKMSERA (in Ref. 1; AAF66443)" FT /evidence="ECO:0000305" FT STRAND 137..143 FT /evidence="ECO:0007829|PDB:1J0W" FT STRAND 153..159 FT /evidence="ECO:0007829|PDB:1J0W" FT STRAND 161..171 FT /evidence="ECO:0007829|PDB:1J0W" FT STRAND 174..180 FT /evidence="ECO:0007829|PDB:1J0W" FT HELIX 181..183 FT /evidence="ECO:0007829|PDB:1J0W" FT STRAND 184..189 FT /evidence="ECO:0007829|PDB:1J0W" FT STRAND 191..198 FT /evidence="ECO:0007829|PDB:1J0W" FT STRAND 200..204 FT /evidence="ECO:0007829|PDB:1J0W" FT STRAND 206..212 FT /evidence="ECO:0007829|PDB:1J0W" FT HELIX 216..229 FT /evidence="ECO:0007829|PDB:1J0W" SQ SEQUENCE 306 AA; 35464 MW; 2F259529E8B068DB CRC64; MASNFNDIVK QGYVRIRSRR LGIYQRCWLV FKKASSKGPK RLEKFSDERA AYFRCYHKVT ELNNVKNVAR LPKSTKKHAI GIYFNDDTSK TFACESDLEA DEWCKVLQME CVGTRINDIS LGEPDLLATG VEREQSERFN VYLMPSPNLD VHGECALQIT YEYICLWDVQ NPRVKLISWP LSALRRYGRD TTWFTFEAGR MCETGEGLFI FQTRDGEAIY QKVHSAALAI AEQHERLLQS VKNSMLQMKM SERAASLSTM VPLPRSAYWQ HITRQHSTGQ LYRLQDVSSP LKLHRTETFP AYRSEH //